IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Pinnacle Financial Partners, Inc.
Symbol: PNFP
Price: Last trade $64.25
Description: Re-offer range $61.25-$63.25
Trade Date: 1/24
Shares: 2.7 million
Underwriter(s)J.P. Morgan
Rating=Subscription Needed
Company: Ocular Therapeutix
Symbol: OCUL
Price: Last trade $7.55
Description: No re-offer range available
Trade Date: 1/24
Shares: 3.3 million
Underwriter(s)Cantor Fitzgerald & Co.
Rating=Subscription Needed
Company: Cascadian Therapeutics, Inc.
Symbol: CASC
Price: Last trade $3.65
Description: No re-offer range available
Trade Date: 1/24
Shares: 20.5 million
Underwriter(s)Cowen & Co., Barclays, Raymond James
Co Manager(s)BTIG
Rating=Subscription Needed
Company: BioAmber Inc.
Symbol: BIOA
Price: Last trade $5.26
Description: No re-offer range available
Trade Date: 1/24
Shares: 1.9 million
Underwriter(s)Rodman & Renshaw
Rating=Subscription Needed
Company: GasLog Partners LP
Symbol: GLOP
Price: Last trade $22.05
Description: Re-offer $20.50-$20.75
Trade Date: 1/24
Shares: 3.75 million
Underwriter(s)Citigroup
Rating=Subscription Needed
Company: US Foods Holding Corp.
Symbol: USFD
Price: Last trade $25.78
Trade Date: 1/26
Shares: 30 million
Underwriter(s)Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Merrill Lynch, Citigroup, Credit Suisse, Wells Fargo, KKR
Co Manager(s)Guggenheim Securities, ING, Rabo Securities, Natixis
Rating=Subscription Needed